Indirect effects of cytomegalovirus infection: Implications for vaccine development

被引：7
|
作者：
Moseley, Philip [1 ]
Klenerman, Paul [2 ,3 ]
Kadambari, Seilesh [4 ,5 ,6 ,7 ]
机构：
[1] Oxford Univ Hosp, Horton Gen Hosp, Dept Paediat, Banbury, England
[2] Univ Oxford, Translat Gastroenterol Unit, Oxford, England
[3] Univ Oxford, Nuffield Dept Med, Oxford, England
[4] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England
[5] NIHR Oxford Biomed Res Ctr, Oxford, England
[6] Great Ormond St Hosp Children NHS Fdn Trust, Dept Paediat Infect Dis, London, England
[7] UCL, Great Ormond St Inst Child Hlth, London, England
来源：
REVIEWS IN MEDICAL VIROLOGY | 2023年 / 33卷 / 01期
关键词：
T-LYMPHOCYTE SUBPOPULATIONS; INFLUENZA VACCINATION; PERIPHERAL-BLOOD; ATHEROSCLEROSIS RISK; COST-EFFECTIVENESS; ADOLESCENT GIRLS; ANTIBODY-LEVELS; CELL RESPONSES; DOUBLE-BLIND; OLD-AGE;
D O I：
10.1002/rmv.2405
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Development of a cytomegalovirus (CMV) vaccine is a high priority due to its significant global impact-contributing to mortality in immunosuppressed individuals, neurodevelopmental delay in infected neonates and non-genetic sensorineural hearing loss. The impact of CMV on the general population has been less well studied; however, a wide range of evidence indicates that CMV may increase the risk of atherosclerosis, cancer, immunosenescence, and progression of tuberculosis (TB) and human immunodeficiency virus. Due to the high seroprevalence of CMV worldwide, any modulation of risk by CMV is likely to have a significant impact on the epidemiology of these diseases. This review will evaluate how CMV may cause morbidity and mortality outside of the neonatal and immunosuppressed populations and consider the potential impact of a CMV vaccine on these outcomes.
引用
收藏
页数：14
相关论文
共 50 条
  • [21] Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice
    Scarpini, Sara
    Morigi, Francesca
    Betti, Ludovica
    Dondi, Arianna
    Biagi, Carlotta
    Lanari, Marcello
    VACCINES, 2021, 9 (06)
  • [22] Prospects for development and potential impact of a vaccine against congenital cytomegalovirus (CMV) infection
    Schlfiss, Mark R.
    JOURNAL OF PEDIATRICS, 2007, 151 (06): : 564 - 570
  • [23] Alteration of direct and indirect effects of cytomegalovirus
    Kamar, Nassim
    Mengelle, Catherine
    Rostaing, Lionel
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2007, 5 (02) : 727 - 730
  • [24] Facing the facts: The indirect effects of cytomegalovirus
    Emery, Vincent
    TRANSPLANTATION, 2007, 84 (06) : S7 - S10
  • [25] DIRECT AND INDIRECT EFFECTS OF THE CYTOMEGALOVIRUS (CMV) INFECTION UPON IMMUNE SYSTEM HOMEOSTASIS AND FUNCTION
    Nikolich-Zugich, J.
    Wertheimer, A. M.
    Park, B.
    Bennett, M. S.
    Nikolich-Zugich, D.
    Pulko, V.
    Uhrlaub, J.
    Smithey, M.
    GERONTOLOGIST, 2014, 54 : 14 - 14
  • [26] Vaccine strategies against human cytomegalovirus infection
    Zhong, Jie
    Khanna, Rajiv
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2007, 5 (03) : 449 - 459
  • [27] WOULD A CYTOMEGALOVIRUS VACCINE PREVENT CONGENITAL INFECTION
    不详
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1992, 67 (07): : 888 - 888
  • [28] CYTOMEGALOVIRUS VACCINE DEVELOPMENT - PAST AND PRESENT
    PLOTKIN, SA
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (03) : 85 - 89
  • [29] Development of novel vaccine strategies against human cytomegalovirus infection based on subviral particles
    Pepperl-Klindworth, S
    Frankenberg, N
    Plachter, B
    JOURNAL OF CLINICAL VIROLOGY, 2002, 25 : S75 - S85
  • [30] DEVELOPMENT OF A VACCINE AGAINST MENTAL-RETARDATION CAUSED BY CYTOMEGALOVIRUS-INFECTION IN UTERO
    ELEK, SD
    STERN, H
    LANCET, 1974, 1 (7845): : 1 - 5
12345